admin

I don’t know why anyone would want to buy AT&T (NYSE:T) stock. Source: Roman Tiraspolsky / Shutterstock.com The moves into content by former CEO Randall Stephenson bombed spectacularly. Shareholders are left with $177 billion in debt and, starting next year, a skinnier dividend. The company’s wireless prospects are decent, but only because it can rip
0 Comments
95.69 The current reading of the Investopedia Anxiety Index is below neutral, indicating a lower level of anxiety. Markets Today U.S. equity markets are pointing to a flat-to-lower open following new record highs for the S&P 500 and the Nasdaq on Wednesday. It was the 51st record close for the benchmark index in 2021, and
0 Comments
Coinbase (NASDAQ:COIN) stock enjoys the first-mover advantage with cryptocurrency and has taken crypto mainstream with its user-friendly investment platform. Source: Primakov / Shutterstock.com Bitcoin (CCC:BTC-USD) has attracted massive interest and investment over the last few months. Investors have high hopes on Bitcoin’s price movement, which has driven BTC higher and it has worked in favor
0 Comments
A look at two more stocks for your aggressive growth stock radar screen. Synaptics: https://www.zacks.com/stock/quote/SYNA?cid=CS-YOUTUBE-FT-VID NeoPhotonics: https://www.zacks.com/stock/quote/NPTN?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
With a bipartisan infrastructure bill and a $3.5 trillion budget resolution making their way through Congress and looking poised to pass, I believe investors are greatly underestimating the extent to which these pieces of legislation will help General Electric (NYSE:GE) and GE stock. Source: Sundry Photography / Shutterstock.com GE operates through four industrial segments — Power,
0 Comments
Stock trading draws Type A personalities who are driven to win at all costs. Succeeding means logging long hours in front of a computer screen, researching, and trading stocks. But in stock trading, there’s a fine line between working hard and feeding an addiction. That line can mean the difference between making sound investment decisions
0 Comments
Cassava Sciences (NASDAQ:SAVA) stock is in a tailspin after a lab denied it had prepared recent results for the biotech’s experimental Alzheimer’s disease treatment. Source: pathdoc / Shutterstock.com Following the news, Cassava shares fell approximately 50%, eliminating roughly $2.4 billion of value over three trading days. The rejection contradicts a statement from Cassava that Quanterix
0 Comments
It’s been a little more than three weeks since Zomedica (NYSEAMERICAN:ZOM) reported its Q2 results. Despite reasonably healthy sales, ZOM stock gained just 14% from Aug. 11 through the end of the month.  Source: Postmodern Studio / Shutterstock.com Another InvestorPlace columnist, Ian Bezek, recently argued that Zomedica needs to raise its revenues considerably before investors
0 Comments
Synopsys is the driving force behind the tech of future and will fit nicely in your portfolio of the future. Synopsys: https://www.zacks.com/stock/quote/SNPS?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
Novavax (NASDAQ:NVAX) stock could trade in the $100 billion market capitalization range like BioNTech (NASDAQ:BNTX) or Moderna (NASDAQ:MRNA). Except, unlike those companies, Novavax has not yet delivered. Source: Ascannio/Shutterstock.com It might be among the most-watched firms that did not yet bring a Covid-19 vaccine to market. Chances are low that it will slump like Altimmune
0 Comments